Page last updated: 2024-09-02

rx 821002 and lassbio-579

rx 821002 has been researched along with lassbio-579 in 1 studies

Compound Research Comparison

Studies
(rx 821002)
Trials
(rx 821002)
Recent Studies (post-2010)
(rx 821002)
Studies
(lassbio-579)
Trials
(lassbio-579)
Recent Studies (post-2010) (lassbio-579)
3170451006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alves, FR; Antonio, CB; Barreiro, EJ; Figueiredo, CD; Fraga, CA; Herzfeldt, V; Moura, BC; Noël, F; Pompeu, TE; Rates, SM1

Other Studies

1 other study(ies) available for rx 821002 and lassbio-579

ArticleYear
Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579.
    European journal of medicinal chemistry, 2013, Volume: 66

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Drug Design; Locomotion; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT2A; Schizophrenia

2013